270 related articles for article (PubMed ID: 31022888)
1. Coumarins and P450s, Studies Reported to-Date.
Foroozesh M; Sridhar J; Goyal N; Liu J
Molecules; 2019 Apr; 24(8):. PubMed ID: 31022888
[TBL] [Abstract][Full Text] [Related]
2. Coumarin-Based Profluorescent and Fluorescent Substrates for Determining Xenobiotic-Metabolizing Enzyme Activities In Vitro.
Raunio H; Pentikäinen O; Juvonen RO
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630278
[TBL] [Abstract][Full Text] [Related]
3. Quantitative structure-activity relationships (QSARs) for inhibitors and substrates of CYP2B enzymes: importance of compound lipophilicity in explanation of potency differences.
Lewis DF; Ito Y; Lake BG
J Enzyme Inhib Med Chem; 2010 Oct; 25(5):679-84. PubMed ID: 20100069
[TBL] [Abstract][Full Text] [Related]
4. P450 structures and oxidative metabolism of xenobiotics.
Lewis DF
Pharmacogenomics; 2003 Jul; 4(4):387-95. PubMed ID: 12831319
[TBL] [Abstract][Full Text] [Related]
5. Cytochromes P450 and metabolism of xenobiotics.
Anzenbacher P; Anzenbacherová E
Cell Mol Life Sci; 2001 May; 58(5-6):737-47. PubMed ID: 11437235
[TBL] [Abstract][Full Text] [Related]
6. Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.
Rendic SP; Guengerich FP
Arch Toxicol; 2021 Feb; 95(2):395-472. PubMed ID: 33459808
[TBL] [Abstract][Full Text] [Related]
7. QSAR models of cytochrome P450 enzyme 1A2 inhibitors using CoMFA, CoMSIA and HQSAR.
Sridhar J; Foroozesh M; Stevens CL
SAR QSAR Environ Res; 2011 Oct; 22(7-8):681-97. PubMed ID: 22004550
[TBL] [Abstract][Full Text] [Related]
8. Mechanism-based inactivation of cytochrome P450 enzymes: chemical mechanisms, structure-activity relationships and relationship to clinical drug-drug interactions and idiosyncratic adverse drug reactions.
Kalgutkar AS; Obach RS; Maurer TS
Curr Drug Metab; 2007 Jun; 8(5):407-47. PubMed ID: 17584015
[TBL] [Abstract][Full Text] [Related]
9. The versatility of the fungal cytochrome P450 monooxygenase system is instrumental in xenobiotic detoxification.
Lah L; Podobnik B; Novak M; Korošec B; Berne S; Vogelsang M; Kraševec N; Zupanec N; Stojan J; Bohlmann J; Komel R
Mol Microbiol; 2011 Sep; 81(5):1374-89. PubMed ID: 21810122
[TBL] [Abstract][Full Text] [Related]
10. Oxidation of endobiotics mediated by xenobiotic-metabolizing forms of human cytochrome.
Niwa T; Murayama N; Yamazaki H
Curr Drug Metab; 2009 Sep; 10(7):700-12. PubMed ID: 19594405
[TBL] [Abstract][Full Text] [Related]
11. Involvement of enzymes other than CYPs in the oxidative metabolism of xenobiotics.
Strolin Benedetti M; Whomsley R; Baltes E
Expert Opin Drug Metab Toxicol; 2006 Dec; 2(6):895-921. PubMed ID: 17125408
[TBL] [Abstract][Full Text] [Related]
12. In Silico Prediction of Cytochrome P450-Mediated Biotransformations of Xenobiotics: A Case Study of Epoxidation.
Zhang J; Ji L; Liu W
Chem Res Toxicol; 2015 Aug; 28(8):1522-31. PubMed ID: 26200167
[TBL] [Abstract][Full Text] [Related]
13. Intersection of the Roles of Cytochrome P450 Enzymes with Xenobiotic and Endogenous Substrates: Relevance to Toxicity and Drug Interactions.
Guengerich FP
Chem Res Toxicol; 2017 Jan; 30(1):2-12. PubMed ID: 27472660
[TBL] [Abstract][Full Text] [Related]
14. Development of new Coumarin-based profluorescent substrates for human cytochrome P450 enzymes.
Juvonen RO; Ahinko M; Huuskonen J; Raunio H; Pentikäinen OT
Xenobiotica; 2019 Sep; 49(9):1015-1024. PubMed ID: 30272491
[TBL] [Abstract][Full Text] [Related]
15. QSAR analysis of thiolactone derivatives using HQSAR, CoMFA and CoMSIA.
Sainy J; Sharma R
SAR QSAR Environ Res; 2015; 26(10):873-92. PubMed ID: 26524489
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing rates and clearance in P450-mediated reactions: QSARs for substrates of the xenobiotic-metabolizing hepatic microsomal P450s.
Lewis DF; Dickins M
Toxicology; 2002 Jan; 170(1-2):45-53. PubMed ID: 11750082
[TBL] [Abstract][Full Text] [Related]
17. Cytochromes P450 in the bioactivation of chemicals.
Ioannides C; Lewis DF
Curr Top Med Chem; 2004; 4(16):1767-88. PubMed ID: 15579107
[TBL] [Abstract][Full Text] [Related]
18. New insights on the marine cytochrome P450 enzymes and their biotechnological importance.
Sharifian S; Homaei A; Kamrani E; Etzerodt T; Patel S
Int J Biol Macromol; 2020 Jan; 142():811-821. PubMed ID: 31622713
[TBL] [Abstract][Full Text] [Related]
19. Engineering cytochrome P450 enzyme systems for biomedical and biotechnological applications.
Li Z; Jiang Y; Guengerich FP; Ma L; Li S; Zhang W
J Biol Chem; 2020 Jan; 295(3):833-849. PubMed ID: 31811088
[TBL] [Abstract][Full Text] [Related]
20. Modeling of human cytochrome p450-mediated drug metabolism using unsupervised machine learning approach.
Korolev D; Balakin KV; Nikolsky Y; Kirillov E; Ivanenkov YA; Savchuk NP; Ivashchenko AA; Nikolskaya T
J Med Chem; 2003 Aug; 46(17):3631-43. PubMed ID: 12904067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
